Chris Miller

Dr. Chris Miller

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2020 in Emotion Review
Verified
Journal Article
Closed access
PDF file
Chris MillerChris Miller
Chris Miller
MSMatthew D. Sacchet
Matthew D. Sacchet
IGIan H. Gotlib
Ian H. Gotlib
Support vector machines (SVMs) are being used increasingly in affective science as a data-driven classification method and feature reduction technique. Whereas traditional statistical methods typically compare group averages on selected variables, SVMs use a predictive algorithm to learn multivariate patterns that optimally discriminate between groups. In this review, we provide a framework for understanding the methods of SVM-based analyses and summarize the findings of seminal studies that use SVMs for classification or data reduction in the behavioral and neural study of emotion and affective disorders. We conclude by discussing promising directions and potential applications of SVMs in future research in affective science.

1 December 2020 in Psychiatry Research
Verified
Journal Article
Closed access
Chris MillerChris Miller
Chris Miller
EDElena G. Davis
Elena G. Davis
LKLucy S. King
Lucy S. King
MSMatthew D. Sacchet
Matthew D. Sacchet
KGKalanit Grill-Spector
Kalanit Grill-Spector
IGIan H. Gotlib
Ian H. Gotlib

3 December 2023 in Journal of Behavior Therapy and Experimental Psychiatry
Verified
Journal Article
Open access
Chris MillerChris Miller
Chris Miller
DHDawson W. Hedges
Dawson W. Hedges
BBBruce Brown
Bruce Brown
JOJoseph Olsen
Joseph Olsen
EBElijah C. Baughan
Elijah C. Baughan

27 February 2026 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Open access
Chris MillerChris Miller
Chris Miller
AHAngela Hickman
Angela Hickman
CBCaitlin Baten
Caitlin Baten
ZAZulaikha Ali
Zulaikha Ali
SKSaneh K. Kahlon
Saneh K. Kahlon
DHDawson W. Hedges
Dawson W. Hedges
Ketamine pharmacotherapy provides a novel treatment option for major depressive disorder (MDD) and has generated a large, growing body of research regarding its biochemical and clinical properties. This narrative review summarizes the history of ketamine's development, beginning as a general anesthetic, continuing with a discovery of its antidepressant properties, and leading up to its landmark FDA approval indicating its usage for treatment-resistant depression (TRD) and MDD with suicidal ideation or behavior. It then reviews the pharmacokinetic properties of both intravenous (IV) ketamine and intranasal (IN) esketamine, including their dosing, bioavailability, onset of action, elimination, and other clinical considerations. Next, it summarizes the mechanisms of action of ketamine, including its primary classification as an NMDA receptor antagonist and the critical importance of its paradoxical AMPA-activated glutamate surge, which thereafter activates a variety of other downstream signaling pathways that promote synaptogenesis and neuroplasticity as well as alterations to mood and reward processing. It then considers the most common adverse effects, including dissociation, sedation, and hypertension, as well as key interactions with benzodiazepines, lamotrigine, antipsychotics, and CYP inhibitors such as SSRIs. Next, it summarizes the efficacy and effectiveness of IV and IN ketamine, which have demonstrated mixed-to-positive antidepressant effects in a limited-to-moderate number of outcome studies in both randomized, controlled trials and real-world, open-label studies; also, comparative outcome studies have demonstrated non-inferiority to other established treatments and combination studies have shown mixed-to-positive gains when combined with those established treatments, including electroconvulsive therapy, pharmacotherapy, transcranial magnetic therapy, and psychotherapy. Finally, this review provides predictions and recommendations for future research, including the development and enhancement of novel therapeutics, identification of predictive markers to advance personalized medicine, and potential applications in the treatment of other disorders.

21 May 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
TFThomas Jeffrey Farrer
Thomas Jeffrey Farrer
JMJonathan Moore
Jonathan Moore
BZBrinley N Zabriskie
Brinley N Zabriskie
MCMorgan Chase
Morgan Chase
Chris MillerChris Miller
Chris Miller
DHDawson W. Hedges
Dawson W. Hedges
Prior research has reported an association between human papillomavirus (HPV) seropositivity and dementia or Alzheimer’s disease. This study aimed to cross-sectionally investigate the association between HPV seropositivity and cognitive function in older adults. The data used for this study were from the 2011–2014 National Health and Nutrition Examination Survey (NHANES) cycles. To account for the complex survey design and missing data, we applied survey-weighted regression models to each imputed dataset, using multiple imputation techniques. Across all cognitive test outcomes, no statistically significant association was observed between HPV status and cognitive performance after controlling for covariates. These findings suggest that there may not be a significant association between HPV infection and cognitive scores in this NHANES sample. Stakeholders, including policymakers and healthcare providers, should consider these findings in their professional decision-making. Future research should investigate the association between HPV seropositivity and cognition using other samples in order to further characterize the association between HPV and cognitive function in older adults.

10 April 2023 in Biological Psychiatry
Verified
Journal Article
Open access
PDF file
SKSaneh Kahlon
Saneh Kahlon
ZAZulaikha Ali
Zulaikha Ali
EPElizabeth Pritchard
Elizabeth Pritchard
SSSarah Saravia
Sarah Saravia
CBCaitlin Baten
Caitlin Baten
Chris MillerChris Miller
Chris Miller
Generalized anxiety disorder (GAD) is highly prevalent and comorbid with other mental disorders and is associated with various clinical symptoms. Functional magnetic resonance imaging (fMRI) has been used to investigate this disorder, but findings among primary studies have been inconsistent and difficult to interpret.